Originally published by our sister publication Specialty Pharmacy Continuum
By Gina Shaw
Side effects and tolerability ranked as the most important clinical concerns for psychiatric clinicians selecting a long-acting injectable antipsychotic (LAI) to prescribe for their patients with schizophrenia, and the dosing frequency preferred was once per month or less often, according to results from the Determining Clinician factors for Implementing LAIs and Defeating Barriers (DECIDE) survey, presented